Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated at

StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Performance Brooklyn ImmunoTherapeutics stock opened at $1.88 on Friday. Brooklyn ImmunoTherapeutics has a 1 year low of $0.17 and a 1 year […]

Related Keywords

Brooklyn Immunotherapeutics , Renaissance Technologies , Brooklyn Immunotherapeutics Inc , Eterna Therapeutics Inc , Exchange Commission , Brooklyn Immunotherapeutics Company Profile , Free Report , Get Free Report , Nyse Btx , Kbtx , Information , Initiated Coverage , Stocknews Com ,